Search results
Results from the WOW.Com Content Network
Pages in category "Memorial Sloan Kettering Cancer Center physicians" The following 15 pages are in this category, out of 15 total. This list may not reflect recent changes .
Memorial Sloan Kettering Cancer Center Dr. Dattatreyudu Nori is a noted Indo-American radiation oncologist . [ 1 ] [ 2 ] He was once named one of the top doctors in America for the treatment of cancers in women by the women's magazine Ladies' Home Journal .
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution in Manhattan in New York City. MSKCC is one of 72 National Cancer Institute–designated Comprehensive Cancer Centers. [3] [4] Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.
In 2017, Diaz became Head of the Solid Tumor Oncology division at Memorial Sloan Kettering. The same year, he was selected to lead the Stand Up to Cancer “Dream Team” against colorectal cancer. [5] Diaz has founded several companies that focus on genomic analyses of cancers, including Inostics, [6] PapGene, [7] and Personal Genome ...
John H. Healey (born 1952) is an American cancer surgeon, researcher, and expert in the surgical treatment of benign and malignant bone tumors and other musculoskeletal cancers. He serves as Chair of the Orthopaedic Service and Stephen P. McDermott Chair in Surgery at Memorial Sloan-Kettering Cancer Center (MSKCC), [ 1 ] as well as Professor of ...
He is the President and CEO of Memorial Sloan Kettering Cancer Center, starting in September 2022. Previously, he was the senior vice president for Medicine and Dean of the University of Alabama at Birmingham School of Medicine and the CEO of both the UAB Health System and the UAB/Ascension St. Vincent's Alliance.
In 1989, she was recruited to Memorial Sloan Kettering Cancer Center by Nael Martini, the Chief of the Thoracic Service in the Department of Surgery. [4] [5] In 2004, she was a part of a team that identified EGFR mutations in patients with non-small cell lung cancer that responded to EGFR tyrosine kinase inhibitors (such as gefitinib and ...